此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Renal Insufficiency And Cardiovascular Events (RIACE)

2015年2月9日 更新者:Giuseppe Pugliese、Diabetic Nephropathy Study Group

Reduced Estimated Glomerular Filtration Rate (eGFR)and Prediction of Cardiovascular Disease and Renal Outcome in Subjects With Type 2 Diabetes: Italian Multicenter Study

Reduced glomerular filtration rate (GFR) has been recently shown to be a powerful predictor of cardiovascular morbidity and mortality in the general population, independent of traditional cardiovascular risk factors.

This observational study is aimed at assessing the association of reduced estimated GFR with cardiovascular morbidity and mortality in a large italian population (at least 15,000 subjects) of type 2 diabetic outpatients over a 4-year follow-up.

研究概览

地位

完全的

详细说明

Reduced GFR has been recently shown to be a powerful predictor of cardiovascular morbidity and mortality in the general population, independent of traditional cardiovascular risk factors. Since type 2 diabetic patients show increased cardiovascular morbidity and mortality as compared with the general population, the identification of predictors of cardiovascular disease in these patients is of fundamental importance for clinical purposes. One of these predictors is increased urinary albumin excretion rate, which is associated with an increased risk of cardiovascular disease more than of end-stage renal disease. However, a growing body of evidence indicates that a significant proportion of normoalbuminuric diabetic patients, particularly with type 2 diabetes, may exhibit reduced GFR. It is currently unknown the predictive role of this abnormality toward cardiovascular events and death, independent of albuminuria and other known risk factors, in the diabetic population.

This observational study is aimed at assessing the association of reduced estimated GFR with cardiovascular morbidity and mortality in a large italian population (at least 15,000 subjects) of type 2 diabetic nondialytic outpatients over a 4-year follow-up.

Secondary endpoints are to assess in this population:

  • the prevalence and incidence of reduced GFR, as classified according to the National Kidney Foundation criteria, and its association with traditional cardiovascular risk factors;
  • the prevalence, incidence and cardiovascular predictivity of micro and macroalbuminuria.

Patients will be recruited from electronic records of 20 italian outpatients diabetic clinics.

Routine anamnestic, clinical, laboratory and instrumental data will be recorded at baseline and over 4 years to obtain information about:

  • renal function (albumin/creatinine ratio, serum creatinine with estimation of glomerular filtration rate [eGFR]);
  • cardiovascular risk factors (smoking, physical activity, family history of diabetes, dyslipidemia, hypertension and cardiovascular disease, BMI and waist circumference, total, LDL, HDL and non-HDL cholesterol, triglycerides, arterial blood pressure and HbA1c);
  • current glucose-, lipid- and blood pressure-lowering and anti-platelet or anti-coagulant treatment;
  • other illnesses;
  • cardiovascular events (myocardial infarction, stroke, lower limb ulcer/gangrene/amputation and coronary, carotid and lower limb revascularization, endovascular/surgical) and deaths.

These data will be derived from the electronic database of each participating center.

Laboratory analyses will be performed in each centre laboratory after proper standardization of analytical techniques.

研究类型

观察性的

注册 (实际的)

15628

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Ascoli Piceno、意大利、63100
        • Mazzoni Hospital, Division of Diabetology
      • Bari、意大利、70124
        • Policlinico Hospital, Division of Endocrinology
      • Bergamo、意大利、24128
        • Ospedali Riuniti di Bergamo, Division of Diabetology
      • Cagliari、意大利、09042
        • Monserrato Hospital, Division of Diabetology
      • Catanzaro、意大利、88100
        • Mater Domini Hospital, Division of Internal Medicine
      • Foggia、意大利、71100
        • Policlinico Hospital, Division of Endocrinology
      • Latina、意大利、04100
        • Santa Maria Goretti Hospital, Division of Diabetology
      • Milano、意大利、20132
        • San Raffaele Hospital
      • Milano、意大利、20122
        • Policlinico - Maggiore Hospital, Division of Endocrinology and Diabetology
      • Milano、意大利、20123
        • San Giuseppe Hospital, Division of Endocrinology
      • Milano、意大利、20142
        • San Paolo Hospital, Division of Internal Medicine
      • Orbassano-Torino、意大利、10043
        • San Luigi Gonzaga Hospital, Division of Diabetes and Metabolic Diseases
      • Padova、意大利、35128
        • Policlinico Hospital, Division of Diabetology
      • Pisa、意大利、56124
        • Cisanello Hospital, Divisions of Diabetology
      • Pisa、意大利、56126
        • Santa Chiara Hospital, Division of Internal Medicine
      • Rome、意大利、00161
        • Policlinico Hospital, Division of Internal Medicine
      • Rome、意大利、00189
        • Sant'Andrea Hospital, Division of Diabetology
      • Siena、意大利、53100
        • Policlinico Le Scotte, Division of Diabetology
      • Torino、意大利、10126
        • Le Molinette - San Giovanni Battista Hospital, Division of Diabetology
      • Verona、意大利、37126
        • Maggiore Hospital, Division of Endocrinology and Metabolic Diseases

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

40年 至 80年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

概率样本

研究人群

Outpatients clinics

描述

Inclusion Criteria:

type 2 diabetes

Exclusion Criteria:

dyalisis or renal transplantation

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

研究衡量的是什么?

主要结果指标

结果测量
大体时间
cardiovascular morbidity and mortality
大体时间:4 years
4 years

次要结果测量

结果测量
大体时间
eGFR, as classified according to the National Kidney Foundation criteria
大体时间:4 years
4 years
micro/macroalbuminuria
大体时间:4 years
4 years
traditional cardiovascular risk factors
大体时间:4 years
4 years

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Giuseppe Pugliese, MD, PhD、Diabetic Nephropathy Study Group
  • 研究主任:Anna Solini, MD, PhD、Diabetic Nephropathy Study Group

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

有用的网址

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2008年6月1日

初级完成 (实际的)

2008年11月1日

研究完成 (实际的)

2015年2月1日

研究注册日期

首次提交

2008年7月10日

首先提交符合 QC 标准的

2008年7月10日

首次发布 (估计)

2008年7月15日

研究记录更新

最后更新发布 (估计)

2015年2月10日

上次提交的符合 QC 标准的更新

2015年2月9日

最后验证

2015年2月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • DNSG-SID 0601

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅